Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.6T | 1.7T | 2.2T | 1.2T |
Cost of revenue | 1.1T | 1.1T | 1.3T | 971.3B |
Gross profit | 517.6B | 547.2B | 888.0B | 245.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 51.6B | 43.1B | 81.4B | 45.2B |
Other operating expenses | 47.6B | 31.3B | 107.3B | 23.7B |
Operating income | 406.2B | 413.1B | 706.4B | 115.4B |
Non operating interest income | ||||
Income | 7.7B | 9.3B | 24.6B | 4.5B |
Expense | 47.3B | 51.6B | 43.0B | 52.1B |
Other income expense | — | — | — | — |
Pretax income | 325.2B | 370.8B | 716.5B | 130.8B |
Tax provision | 86.0B | 95.4B | 224.9B | 55.0B |
Net income | 239.2B | 275.4B | 491.6B | 75.8B |
Basic EPS | — | 158 | — | — |
Diluted EPS | — | 158 | — | — |
Basic average shares | — | 1.8B | — | — |
Diluted average shares | — | 1.8B | — | — |
EBITDA | 375.6B | 427.4B | 800.3B | 188.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 11.6B | 12.2B | 9.7B | 11.3B |
Preferred stock dividends | 0 | 0 | 0 | 0 |